168 related articles for article (PubMed ID: 9704164)
41. Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment.
Pisanu C; Katsila T; Patrinos GP; Squassina A
Pharmacogenomics; 2018 Jan; 19(2):129-143. PubMed ID: 29199496
[TBL] [Abstract][Full Text] [Related]
42. The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review.
Deb S; Chaplin R; Sohanpal S; Unwin G; Soni R; Lenotre L
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):107-13. PubMed ID: 18197949
[TBL] [Abstract][Full Text] [Related]
43. Anticonvulsant drugs in bipolar disorder.
Grunze H; Schlösser S; Amann B; Walden J
Dialogues Clin Neurosci; 1999 Jun; 1(1):24-40. PubMed ID: 22033602
[TBL] [Abstract][Full Text] [Related]
44. Calcium Channel Antagonists for Mood Disorders.
Dubovsky SL; Marshall D
J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):188-197. PubMed ID: 35185116
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic Interactions between Antiepileptic and Antidepressant Drugs.
Mula M; Trimble MR
World J Biol Psychiatry; 2003 Jan; 4(1):21-4. PubMed ID: 12582973
[TBL] [Abstract][Full Text] [Related]
46. Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices.
Barry JJ; Lembke A; Bullock KD
Clin EEG Neurosci; 2004 Jan; 35(1):4-13. PubMed ID: 15112459
[TBL] [Abstract][Full Text] [Related]
47. [Lithium and other preventive agents of affective disorders in 1983].
Soucek K; Zvolský P
Cesk Psychiatr; 1984 Aug; 80(4):247-51. PubMed ID: 6499034
[No Abstract] [Full Text] [Related]
48. The action of mood-stabilizers in affective disorders: an integrative view as a challenge.
Emrich HM; Dose M; Wolf R
Neuropsychobiology; 1993; 27(3):158-62. PubMed ID: 8232832
[TBL] [Abstract][Full Text] [Related]
49. Predicting response to lithium in mood disorders: role of genetic polymorphisms.
Serretti A; Artioli P
Am J Pharmacogenomics; 2003; 3(1):17-30. PubMed ID: 12562213
[TBL] [Abstract][Full Text] [Related]
50. [Central effect of calcium channel antagonists: new therapeutic possibilities in neurology and psychiatry?].
Kostowski W; Puciłowski O
Psychiatr Pol; 1990; 24(3):209-16. PubMed ID: 2084729
[No Abstract] [Full Text] [Related]
51. Use of ecological momentary assessment in mood disorders research.
Wenze SJ; Miller IW
Clin Psychol Rev; 2010 Aug; 30(6):794-804. PubMed ID: 20619520
[TBL] [Abstract][Full Text] [Related]
52. Mood stabilizers in the treatment of substance use disorders.
Maremmani I; Pacini M; Lamanna F; Pani PP; Perugi G; Deltito J; Salloum IM; Akiskal H
CNS Spectr; 2010 Feb; 15(2):95-109. PubMed ID: 20414155
[TBL] [Abstract][Full Text] [Related]
53. The 'collateral side' of mood stabilizers: safety and evidence-based strategies for managing side effects.
Orsolini L; Pompili S; Volpe U
Expert Opin Drug Saf; 2020 Nov; 19(11):1461-1495. PubMed ID: 32893696
[TBL] [Abstract][Full Text] [Related]
54. Thyroid hormones in treatment of mood disorders.
Chakrabarti S; Malhotra
Indian J Med Sci; 2001 Sep; 55(9):501-7. PubMed ID: 11887301
[TBL] [Abstract][Full Text] [Related]
55. Practical therapeutics: the use of carbamazepine in affective disorders.
Obel AO; Odwako DB
East Afr Med J; 1985 Mar; 62(3):224-8. PubMed ID: 4017925
[No Abstract] [Full Text] [Related]
56. L-Methylfolate Calcium Supplementation in Adolescents and Children: A Retrospective Analysis.
Rainka M; Aladeen T; Westphal E; Meaney J; Gengo F; Greger J; Capote H
J Psychiatr Pract; 2019 Jul; 25(4):258-267. PubMed ID: 31291206
[TBL] [Abstract][Full Text] [Related]
57. Carbamazepine in psychiatry: a review.
Israel M; Beaudry P
Can J Psychiatry; 1988 Oct; 33(7):577-84. PubMed ID: 3058289
[TBL] [Abstract][Full Text] [Related]
58. Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS).
Klesmer J; Badescu R
Curr Psychiatry Rep; 2002 Jun; 4(3):222-7. PubMed ID: 12003686
[TBL] [Abstract][Full Text] [Related]
59. Anticonvulsants in anxiety disorders.
Kinrys G; Wygant LE
Curr Psychiatry Rep; 2005 Aug; 7(4):258-67. PubMed ID: 16098279
[TBL] [Abstract][Full Text] [Related]
60. Lamotrigine.
Willmore LJ
Expert Rev Neurother; 2001 Sep; 1(1):33-42. PubMed ID: 19811044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
